Arcus Biosciences, Inc.
RCUS· NYSE
Arcus Biosciences, Inc.
- Last sale
- Oct 1, 2026 · -2.67%
- Market cap
- $3.21B
- 127.33M shares
- Filings
- 602
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $247,000,000 | reported | |
| FY 2024 | 2024-12-31 | $258,000,000 | reported | |
| FY 2023 | 2023-12-31 | $117,000,000 revised | reported | |
| FY 2022 | 2022-12-31 | $38,000,000 revised | reported | |
| FY 2021 | 2021-12-31 | $383,000,000 | reported | |
| FY 2020 | 2020-12-31 | $78,000,000 revised | reported | |
| FY 2019 | 2019-12-31 | $15,000,000 | reported | |
| FY 2018 | 2018-12-31 | $8,353,000 | reported | |
| FY 2017 | 2017-12-31 | $1,413,000 | reported |
Arcus Biosciences, Inc. · CIK 1724521 · Engraved from SEC EDGAR
